跳至主要内容
临床试验/IRCT20240223061090N1
IRCT20240223061090N1招募中3 期

A comparative study of the effects of platelet-rich plasma, platelet-rich fibrin and methylprednisolone injections in the treatment of knee arthrosis.

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • Patients based on ACR (American college of rheumatology) radiological criteria with knee Grade I, II and III osteoarthritis

排除标准

  • Patients who are breastfeeding or pregnant
  • They have rheumatoid arthritis or severe heart disease.
  • Have a skin infection at the injection site
  • Be a consumer of immunosuppressive drugs or anticoagulants such as warfarin and heparin
  • A history of bleeding or a description of clotting disorders or anemia
  • Have current back pain with spreading to lower limbs
  • Have a history of knee surgery in the last three months
  • Have an active infection or malignancy within the previous 6 months
  • Substance abuse
  • Intra-articular corticosteroid injections in the last 2 months or hyaluronic acid in the last 6 months

研究者

相似试验

comparison of the effects of platelet-rich plasma,... | 临床试验